131 related articles for article (PubMed ID: 2658141)
1. Evaluation of the efficacy and tolerance of intravenously administered imipenem/cilastatin in the treatment of septicaemia.
Linton DM; Aitchison JM; Potgieter PD
S Afr Med J; 1989 Jun; 75(11):529-31. PubMed ID: 2658141
[TBL] [Abstract][Full Text] [Related]
2. Imipenem/cilastatin treatment of acute infections in AIDS/ARC patients.
Giacometti A; Pongetti P; Petrelli E; Scalise G
J Chemother; 1990 Aug; 2(4):247-51. PubMed ID: 2230909
[TBL] [Abstract][Full Text] [Related]
3. Imipenem/cilastatin in the treatment of severe nosocomial pneumonia.
Potgieter PD; Linton DM; Forder AA; Plumb H
S Afr Med J; 1988 Oct; 74(8):390-2. PubMed ID: 3187816
[TBL] [Abstract][Full Text] [Related]
4. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
Nichols RL; Smith JW; Geckler RW; Wilson SE
South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
[TBL] [Abstract][Full Text] [Related]
5. Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.
Hartenauer U; Weilemann LS; Bodmann KF; Ritzerfeld WW; Asmus S; Koch EM
J Hosp Infect; 1990 Apr; 15 Suppl A():61-4. PubMed ID: 1971647
[TBL] [Abstract][Full Text] [Related]
6. [Meropenem (Merrem) vs imipenem/cilastatin in hospital treatment of intra-abdominal infections. A multicenter study].
Tonelli F
Minerva Chir; 1997 Mar; 52(3):317-26. PubMed ID: 9148225
[TBL] [Abstract][Full Text] [Related]
7. Imipenem/cilastatin as secondary therapy for bacterial infections.
Kono K; Onuki K; Tohara S; Takeda S
Clin Ther; 1991; 13(4):448-56. PubMed ID: 1933995
[TBL] [Abstract][Full Text] [Related]
8. Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.
Sims M; Mariyanovski V; McLeroth P; Akers W; Lee YC; Brown ML; Du J; Pedley A; Kartsonis NA; Paschke A
J Antimicrob Chemother; 2017 Sep; 72(9):2616-2626. PubMed ID: 28575389
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular imipenem/cilastatin in multiple-dose treatment regimens: review of the worldwide clinical experience.
Garau J; Calandra GB
Chemotherapy; 1991; 37 Suppl 2():44-52. PubMed ID: 1879187
[TBL] [Abstract][Full Text] [Related]
10. Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Geddes A; Thaler M; Schonwald S; Härkönen M; Jacobs F; Nowotny I
J Antimicrob Chemother; 1999 Dec; 44(6):799-810. PubMed ID: 10590282
[TBL] [Abstract][Full Text] [Related]
11. Imipenem/cilastatin (Primaxin): evaluation in general surgical practice.
Chin MJ; Bagshaw PF; Bremner JM
N Z Med J; 1991 Jan; 104(904):22-3. PubMed ID: 2008258
[No Abstract] [Full Text] [Related]
12. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of intramuscular imipenem/cilastatin sodium in surgical infections].
Konaga E; Takeuchi H; Orita K; Fuchimoto S; Ogawa K; Kitagawa T; Tokuda N; Kimura H; Hamada F; Nishiyama Y
Jpn J Antibiot; 1991 Dec; 44(12):1341-50. PubMed ID: 1798068
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of imipenem/cilastatin sodium as a second line regimen in severe infections associated with hematologic disorders].
Tsuda S; Nakai H; Murakami T; Seryu S; Takashima T; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Nishida K
Jpn J Antibiot; 1991 Aug; 44(8):886-98. PubMed ID: 1920814
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.
Fink MP; Snydman DR; Niederman MS; Leeper KV; Johnson RH; Heard SO; Wunderink RG; Caldwell JW; Schentag JJ; Siami GA
Antimicrob Agents Chemother; 1994 Mar; 38(3):547-57. PubMed ID: 8203853
[TBL] [Abstract][Full Text] [Related]
16. Imipenem-cilastatin. A new dimension.
S Afr Med J; 1988 Nov; 74(9 Suppl):1-8. PubMed ID: 3187839
[TBL] [Abstract][Full Text] [Related]
17. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
Bartoloni A; Strohmeyer M; Corti G; Buonomini MI; Franchino L; Romanelli G; Moretti AM; De Vizzi GB; Petraglia A; Mancini P; Atzeni R; Fogliani V; Giura R; Paradisi F
Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology].
Chimura T; Banzai M; Yamazaki K; Miyata R; Yokoyama Y; Matsuo M; Oda T; Kihara K; Kanasugi H; Takahashi H
Jpn J Antibiot; 1991 Dec; 44(12):1351-8. PubMed ID: 1798069
[TBL] [Abstract][Full Text] [Related]
19. Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
Kahan FM; Rogers JD
Chemotherapy; 1991; 37 Suppl 2():21-5. PubMed ID: 1879183
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology].
Matsuda S; Oh K; Tateno M; Kojima Y; Hirabayashi K; Okada E; Doko F; Kawai J
Jpn J Antibiot; 1991 Dec; 44(12):1359-67. PubMed ID: 1798070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]